MMP16 and neoplasm: Considering MT1‐MMP is a primary driving force of tumor progression in most cancer types 26, including esophageal cancer 22; it has recently been reported that MT3‐MMP acts to antagonize MT1‐MMP‐driven tumor cell invasion 5.